Vanberra Signal

Hememics Biotechnologies

Curated by Signal

Developer of techology platform for biopreservation

Overview

HeMemics Biotechnologies specializes in the field of biopreservation. The company's products are based on its patented HeMeDri technology platform for preserving and storing of mammalian cells and perishable biologics. The company's patented preservation solutions, HemSol, are designed to preserve mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature. The company also provide customized solutions to clients that need to stabilize their products in dried/non-dried, instead of frozen format, for ease of storage and transportation. It can be used to preserve and dehydrate/rehydrate perishable biologics (proteins, cells, and tissues.).

Key facts

Founded
2009

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a medical diagnosis platform to analyze genome of cancer patients

    Life Sciences TechnologyNew York City, United States
  • Developer of a non-invasive test to detect health conditions through the eyes

    Life Sciences TechnologyGuilford, United States
  • Providing analytics platform for genome analysis.

    Life Sciences TechnologyCambridge, United States

About Hememics Biotechnologies

What does Hememics Biotechnologies do?

HeMemics Biotechnologies specializes in the field of biopreservation.

Where is Hememics Biotechnologies headquartered?

Hememics Biotechnologies is headquartered in Gaithersburg, United States.

When was Hememics Biotechnologies founded?

Hememics Biotechnologies was founded in 2009.

Which sector is Hememics Biotechnologies in?

Hememics Biotechnologies operates in Life Sciences Technology.

Who are Hememics Biotechnologies's competitors?

Companies similar to Hememics Biotechnologies include Isabl, Identifeye Health, and NextCode Health.